Mohanty, S. Et Al. 2019. Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation. AHA’xxs Scientific Sessions 2019 , (Philadelphia, United States Of America), 10717.

Mohanty, S., Trivedi, C., Della Rocca, D., Gianni, C., Bassiouny, M., CANPOLAT, U., ... MacDonald, B.(2019). Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation . AHA’xxs Scientific Sessions 2019 (pp.10717). Philadelphia, United States Of America

Mohanty, Sanghamitra Et Al. "Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation," AHA’xxs Scientific Sessions 2019, Philadelphia, United States Of America, 2019

Mohanty, Sanghamitra Et Al. "Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation." AHA’xxs Scientific Sessions 2019 , Philadelphia, United States Of America, pp.10717, 2019

Mohanty, S. Et Al. (2019) . "Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation." AHA’xxs Scientific Sessions 2019 , Philadelphia, United States Of America, p.10717.

@conferencepaper{conferencepaper, author={Sanghamitra Mohanty Et Al. }, title={Abstract 10717: Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation}, congress name={AHA’xxs Scientific Sessions 2019}, city={Philadelphia}, country={United States Of America}, year={2019}, pages={10717} }